{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T17:52:09Z","timestamp":1772646729137,"version":"3.50.1"},"reference-count":172,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDDT"],"published-print":{"date-parts":[[2020,9,8]]},"abstract":"<jats:sec><jats:title>Background and Objective:<\/jats:title><jats:p>Infectious diseases are amongst the leading causes of death in the world and central nervous system infections produced by viruses may either be fatal or generate a wide range of symptoms that affect global human health. Most antiviral plants contain active phytoconstituents such as alkaloids, flavonoids, and polyphenols, some of which play an important antiviral role. Herein, we present a background to viral central nervous system (CNS) infections, followed by a review of medicinal plants and bioactive compounds that are effective against viral pathogens in CNS infections.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>A comprehensive literature search was conducted on scientific databases including: PubMed, Scopus, Google Scholar, and Web of Science. The relevant keywords used as search terms were: \u201cmyelitis\u201d, \u201cencephalitis\u201d, \u201cmeningitis\u201d, \u201cmeningoencephalitis\u201d, \u201cencephalomyelitis\u201d, \u201ccentral nervous system\u201d, \u201cbrain\u201d, \u201cspinal cord\u201d, \u201cinfection\u201d, \u201cvirus\u201d, \u201cmedicinal plants\u201d, and \u201cbiological compounds\u201d.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>The most significant viruses involved in central nervous system infections are: Herpes Simplex Virus (HSV), Varicella Zoster Virus (VZV), West Nile Virus (WNV), Enterovirus 71 (EV71), Japanese Encephalitis Virus (JEV), and Dengue Virus (DENV). The inhibitory activity of medicinal plants against CNS viruses is mostly active through prevention of viral binding to cell membranes, blocking viral genome replication, prevention of viral protein expression, scavenging reactive Oxygen Species (ROS), and reduction of plaque formation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Due to the increased resistance of microorganisms (bacteria, viruses, and parasites) to antimicrobial therapies, alternative treatments, especially using plant sources and their bioactive constituents, appear to be more fruitful.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1570163816666190715114741","type":"journal-article","created":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T12:45:13Z","timestamp":1563281113000},"page":"469-483","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effective Antiviral Medicinal Plants and Biological Compounds Against Central Nervous System Infections: A Mechanistic Review"],"prefix":"10.2174","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0668-4493","authenticated-orcid":true,"given":"Khojasteh","family":"Malekmohammad","sequence":"first","affiliation":[{"name":"Department of Animal Sciences, Faculty of Basic Sciences, Shahrekord University, Shahrekord, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1860-1141","authenticated-orcid":true,"given":"Mahmoud","family":"Rafieian-Kopaei","sequence":"additional","affiliation":[{"name":"Medical Plants Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9440-3083","authenticated-orcid":true,"given":"Samira","family":"Sardari","sequence":"additional","affiliation":[{"name":"Department of Pathobiology, Faculty of Veterinary Medicine, Shahrekord University, Shahrekord, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1702-5100","authenticated-orcid":true,"given":"Robert D.E.","family":"Sewell","sequence":"additional","affiliation":[{"name":"Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff CF10 3NB, Wales, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s13337-015-0276-6","volume":"26","author":"Ganjhu R.K.","year":"2015","unstructured":"Ganjhu R.K.; Mudgal P.P.; Maity H.; Herbal plants and plant preparations as remedial approach for viral diseases. Virusdisease 2015,26(4),225-236","journal-title":"Virusdisease"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ijsu.2010.11.001","volume":"9","author":"Muzumdar D.","year":"2011","unstructured":"Muzumdar D.; Central nervous system infections and the neurosurgeon: a perspective. Int J Surg 2011,9(2),113-116","journal-title":"Int J Surg"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.4103\/0976-3147.116472","volume":"4","author":"Alvis Miranda H.","year":"2013","unstructured":"Alvis Miranda H.; Castellar-Leones S.M.; Elzain M.A.; Moscote-Salazar L.R.; Brain abscess: Current management. J Neurosci Rural Pract 2013,4(Suppl. 1),S67-S81","journal-title":"J Neurosci Rural Pract"},{"key":"ref=4","first-page":"220","volume":"6","author":"Sahoo S.","year":"2018","unstructured":"Sahoo S.; A review of some medicinal plants used for nervous disorders. J Med Plant 2018,6,220-224","journal-title":"J Med Plant"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(02)07681-X","volume":"359","author":"Whitley R.J.","year":"2002","unstructured":"Whitley R.J.; Gnann J.W.; Viral encephalitis: familiar infections and emerging pathogens. Lancet 2002,359(9305),507-513","journal-title":"Lancet"},{"key":"ref=6","author":"Hsu C.C.","unstructured":"Hsu C.C.; Epidemiological Features of Central Nervous System (CNS) Infections in Taiwan and Molecular Investigation of CNS Infections of Unknown Cause. PhD dissertation Columbia University 2012","journal-title":"Columbia University 2012"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1542\/pir.20-6-192","volume":"20","author":"Whitley R.J.","year":"1999","unstructured":"Whitley R.J.; Kimberlin D.W.; Viral encephalitis. Pediatr Rev 1999,20(6),192-198","journal-title":"Pediatr Rev"},{"key":"ref=8","doi-asserted-by":"publisher","DOI":"10.1177\/1179573517703342","author":"Bookstaver P.B.","year":"2017","unstructured":"Bookstaver P.B.; Mohorn P.L.; Shah A.; Management of viral central nervous system infections: a primer for clinicians. J Cent Nerv Syst Dis 2017","journal-title":"J Cent Nerv Syst Dis"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/j.1468-1331.2010.02970.x","volume":"17","author":"Steiner I.","year":"2010","unstructured":"Steiner I.; Budka H.; Chaudhuri A.; Viral meningoencephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol 2010,17(8),999-e57","journal-title":"Eur J Neurol"},{"key":"ref=10","first-page":"15","volume":"9","author":"Ramamurthy M.","year":"2016","unstructured":"Ramamurthy M.; Sankara S.; Arumugam I.; Nandagopal B.; Srikanth P.; Gopalan S.; Viral infections of the CNS: the unraveling of the mystery. Sri Ramachandra J Med 2016,9,15-23","journal-title":"Sri Ramachandra J Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.coviro.2014.12.009","volume":"11","author":"Swanson P.A.","year":"2015","unstructured":"Swanson P.A.; McGavern D.B.; Viral diseases of the central nervous system. Curr Opin Virol 2015,11,44-54","journal-title":"Curr Opin Virol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nri2971","volume":"11","author":"McGavern D.B.","year":"2011","unstructured":"McGavern D.B.; Kang S.S.; Illuminating viral infections in the nervous system. Nat Rev Immunol 2011,11(5),318-329","journal-title":"Nat Rev Immunol"},{"key":"ref=13","first-page":"42","volume":"2","author":"Shubhada V.M.","year":"2017","unstructured":"Shubhada V.M.; Dharammali, Dinesh RC. Herbal remedies for CNS disorders. IJCAP 2017,2,42-44","journal-title":"IJCAP"},{"key":"ref=14","first-page":"110","volume":"1","author":"Roy R.N.","year":"2016","unstructured":"Roy R.N.; Commentary: \u201cPhysicochemical Characterization and Antibacterial Activity of the Leaf oil of Crotalaria pallida Aiton. Journal of Meningitis 2016,1,110","journal-title":"Journal of Meningitis"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.2174\/138955708785909943","volume":"8","author":"Naithani R.","year":"2008","unstructured":"Naithani R.; Huma L.C.; Holland L.E.; Antiviral activity of phytochemicals: a comprehensive review. Mini Rev Med Chem 2008,8(11),1106-1133","journal-title":"Mini Rev Med Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.nbt.2009.03.007","volume":"25","author":"Chattopadhyay D.","year":"2009","unstructured":"Chattopadhyay D.; Sarkar M.C.; Chatterjee T.; Recent advancements for the evaluation of anti-viral activities of natural products. N Biotechnol 2009,25(5),347-368","journal-title":"N Biotechnol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.diii.2012.04.020","volume":"93","author":"Sarrazin J.L.","year":"2012","unstructured":"Sarrazin J.L.; Bonneville F.; Martin-Blondel G.; Brain infections. Diagn Interv Imaging 2012,93(6),473-490","journal-title":"Diagn Interv Imaging"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.reprotox.2006.02.001","volume":"21","author":"Mendelson E.","year":"2006","unstructured":"Mendelson E.; Aboudy Y.; Smetana Z.; Tepperberg M.; Grossman Z.; Laboratory assessment and diagnosis of congenital viral infections: Rubella, cytomegalovirus (CMV), varicella-zoster virus (VZV), herpes simplex virus (HSV), parvovirus B19 and human immunodeficiency virus (HIV). Reprod Toxicol 2006,21(4),350-382","journal-title":"Reprod Toxicol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev-micro-092611-150051","volume":"66","author":"Smith G.","year":"2012","unstructured":"Smith G.; Herpesvirus transport to the nervous system and back again. Annu Rev Microbiol 2012,66,153-176","journal-title":"Annu Rev Microbiol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neurol.2011.12.006","volume":"168","author":"Gessain A.","year":"2012","unstructured":"Gessain A.; Mahieux R.; Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects. Rev Neurol (Paris) 2012,168(3),257-269","journal-title":"Rev Neurol (Paris)"},{"key":"ref=21","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7549252","author":"Akkoc G","unstructured":"Akkoc G; Kadayifci EK; Karaaslan A; Atici S; Yakut N; Ocal Demir S; Epstein-Barr virus encephalitis in an immunocompetent child: a case report and management of Epstein-Barr virus encephalitis Case Rep Infect Dis 2012 2016","journal-title":"Epstein-Barr virus encephalitis in an immunocompetent child: a case report and management of Epstein-Barr virus encephalitis"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0072-9752(07)85013-5","volume":"85","author":"Berger J.R.","year":"2007","unstructured":"Berger J.R.; Progressive multifocal leukoencephalopathy. Handb Clin Neurol 2007,85,169-183","journal-title":"Handb Clin Neurol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S1473-3099(09)70226-9","volume":"9","author":"Cinque P.","year":"2009","unstructured":"Cinque P.; Koralnik I.J.; Gerevini S.; Miro J.M.; Price R.W.; Progressive multifocal leukoencephalopathy in HIV-1 infection. Lancet Infect Dis 2009,9(10),625-636","journal-title":"Lancet Infect Dis"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1177\/1073858409356594","volume":"16","author":"Focosi D.","year":"2010","unstructured":"Focosi D.; Marco T.; Kast R.E.; Maggi F.; Ceccherini-Nelli L.; Petrini M.; Progressive multifocal leukoencephalopathy: what\u2019s new? Neuroscientist 2010,16(3),308-323","journal-title":"Neuroscientist"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1146\/annurev.med.080708.082655","volume":"61","author":"Major E.O.","year":"2010","unstructured":"Major E.O.; Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu Rev Med 2010,61,35-47","journal-title":"Annu Rev Med"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"9200","DOI":"10.1128\/JVI.00609-10","volume":"84","author":"Tan C.S.","year":"2010","unstructured":"Tan C.S.; Ellis L.C.; W\u00fcthrich C.; JC virus latency in the brain and extraneural organs of patients with and without progressive multifocal leukoencephalopathy. J Virol 2010,84(18),9200-9209","journal-title":"J Virol"},{"key":"ref=27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000368","volume":"5","author":"Sunyaev S.R.","year":"2009","unstructured":"Sunyaev S.R.; Lugovskoy A.; Simon K.; Gorelik L.; Adaptive mutations in the JC virus protein capsid are associated with progressive multifocal leukoencephalopathy (PML). PLoS Genet 2009,5(2)","journal-title":"PLoS Genet"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/S1474-4422(10)70095-8","volume":"9","author":"Gonzalez H.","year":"2010","unstructured":"Gonzalez H.; Olsson T.; Borg K.; Management of postpolio syndrome. Lancet Neurol 2010,9(6),634-642","journal-title":"Lancet Neurol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1001\/archneurol.2009.153","volume":"66","author":"Tyler K.L.","year":"2009","unstructured":"Tyler K.L.; Emerging viral infections of the central nervous system: part 1. Arch Neurol 2009,66(8),939-948","journal-title":"Arch Neurol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1212\/WNL.0000000000001177","volume":"84","author":"Wasay M.","year":"2015","unstructured":"Wasay M.; Khatri I.A.; Abd-Allah F.; Arbovirus infections of the nervous system: current trends and future threats. Neurology 2015,84(4),421-423","journal-title":"Neurology"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.2174\/187152409787601905","volume":"9","author":"Domingues R.B.","year":"2009","unstructured":"Domingues R.B.; Treatment of viral encephalitis. Cent Nerv Syst Agents Med Chem 2009,9(1),56-62","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1053\/spid.2003.127223","volume":"14","author":"Romero J.R.","year":"2003","unstructured":"Romero J.R.; Newland J.G.; Viral meningitis and encephalitis: traditional and emerging viral agents. Semin Pediatr Infect Dis 2003,14(2),72-82","journal-title":"Semin Pediatr Infect Dis"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.emc.2008.07.004","volume":"27","author":"Somand D.","year":"2009","unstructured":"Somand D.; Meurer W.; Central nervous system infections. Emerg Med Clin North Am ix2009,27(1),89-100","journal-title":"Emerg Med Clin North Am"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1056\/NEJM200103153441103","volume":"344","author":"McJunkin J.E.","year":"2001","unstructured":"McJunkin J.E.; de los Reyes E.C.; Irazuzta J.E.; La Crosse encephalitis in children. N Engl J Med 2001,344(11),801-807","journal-title":"N Engl J Med"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0022-510X(02)00017-5","volume":"195","author":"H\u00e4usler M.","year":"2002","unstructured":"H\u00e4usler M.; Schaade L.; Kem\u00e9ny S.; Schweizer K.; Schoenmackers C.; Ramaekers V.T.; Encephalitis related to primary varicella-zoster virus infection in immunocompetent children. J Neurol Sci 2002,195(2),111-116","journal-title":"J Neurol Sci"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0065-3527(03)60008-4","volume":"60","author":"Chambers T.J.","year":"2003","unstructured":"Chambers T.J.; Diamond M.S.; Pathogenesis of flavivirus encephalitis. Adv Virus Res 2003,60,273-342","journal-title":"Adv Virus Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1080\/13550280591002450","volume":"11","author":"Olival K.J.","year":"2005","unstructured":"Olival K.J.; Daszak P.; The ecology of emerging neurotropic viruses. J Neurovirol 2005,11(5),441-446","journal-title":"J Neurovirol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1056\/NEJMp058263","volume":"355","author":"Solomon T.","year":"2006","unstructured":"Solomon T.; Control of Japanese encephalitis--within our grasp? N Engl J Med 2006,355(9),869-871","journal-title":"N Engl J Med"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"S294","DOI":"10.1086\/533419","volume":"197","author":"Price R.W.","year":"2008","unstructured":"Price R.W.; Spudich S.; Antiretroviral therapy and central nervous system HIV type 1 infection. J Infect Dis 2008,197(Suppl. 3),S294-S306","journal-title":"J Infect Dis"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/nen.0b013e318163a990","volume":"67","author":"Wong K.T.","year":"2008","unstructured":"Wong K.T.; Munisamy B.; Ong K.C.; The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways. J Neuropathol Exp Neurol 2008,67(2),162-169","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1056\/NEJMp1104329","volume":"364","author":"Aylward B.","year":"2011","unstructured":"Aylward B.; Yamada T.; The polio endgame. N Engl J Med 2011,364(24),2273-2275","journal-title":"N Engl J Med"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1093\/ije\/dym207","volume":"36","author":"Campbell H.","year":"2007","unstructured":"Campbell H.; Andrews N.; Brown K.E.; Miller E.; Review of the effect of measles vaccination on the epidemiology of SSPE. Int J Epidemiol 2007,36(6),1334-1348","journal-title":"Int J Epidemiol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/clinids\/21.3.571","volume":"21","author":"McCullers J.A.","year":"1995","unstructured":"McCullers J.A.; Lakeman F.D.; Whitley R.J.; Human herpesvirus 6 is associated with focal encephalitis. Clin Infect Dis 1995,21(3),571-576","journal-title":"Clin Infect Dis"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1750-3639.2001.tb00413.x","volume":"11","author":"Kleinschmidt-DeMasters B.K.","year":"2001","unstructured":"Kleinschmidt-DeMasters B.K.; Gilden D.H.; The expanding spectrum of herpesvirus infections of the nervous system. Brain Pathol 2001,11(4),440-451","journal-title":"Brain Pathol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1086\/427944","volume":"40","author":"Isaacson E.","year":"2005","unstructured":"Isaacson E.; Glaser C.A.; Forghani B.; Evidence of human herpesvirus 6 infection in 4 immunocompetent patients with encephalitis. Clin Infect Dis 2005,40(6),890-893","journal-title":"Clin Infect Dis"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/ana.21611","volume":"65","author":"Yao K.","year":"2009","unstructured":"Yao K.; Honarmand S.; Espinosa A.; Akhyani N.; Glaser C.; Jacobson S.; Detection of human herpesvirus-6 in cerebrospinal fluid of patients with encephalitis. Ann Neurol 2009,65(3),257-267","journal-title":"Ann Neurol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S1474-4422(13)70150-9","volume":"12","author":"Carod-Artal F.J.","year":"2013","unstructured":"Carod-Artal F.J.; Wichmann O.; Farrar J.; Gasc\u00f3n J.; Neurological complications of dengue virus infection. Lancet Neurol 2013,12(9),906-919","journal-title":"Lancet Neurol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1177\/088307380001500809","volume":"15","author":"Kankirawatana P.","year":"2000","unstructured":"Kankirawatana P.; Chokephaibulkit K.; Puthavathana P.; Yoksan S.; Apintanapong S.; Pongthapisit V.; Dengue infection presenting with central nervous system manifestation. J Child Neurol 2000,15(8),544-547","journal-title":"J Child Neurol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/00006454-200102000-00020","volume":"20","author":"Chokephaibulkit K.","year":"2001","unstructured":"Chokephaibulkit K.; Kankirawatana P.; Apintanapong S.; Viral etiologies of encephalitis in Thai children. Pediatr Infect Dis J 2001,20(2),216-218","journal-title":"Pediatr Infect Dis J"},{"key":"ref=50","first-page":"114","volume":"28","author":"Garc\u00eda-Rivera E.J.","year":"2009","unstructured":"Garc\u00eda-Rivera E.J.; Vorndam V.; Rigau-P\u00e9rez J.G.; Use of an enhanced surveillance system for encephalitis and aseptic meningitis for the detection of neurologic manifestations of dengue in Puerto Rico, 2003. P R Health Sci J 2009,28(2),114-120","journal-title":"P R Health Sci J"},{"key":"ref=51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000854","volume":"4","author":"Le V.T.","year":"2010","unstructured":"Le V.T.; Phan T.Q.; Do Q.H.; Viral etiology of encephalitis in children in southern Vietnam: results of a one-year prospective descriptive study. PLoS Negl Trop Dis 2010,4(10)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jns.2011.01.012","volume":"303","author":"Soares C.N.","year":"2011","unstructured":"Soares C.N.; Cabral-Castro M.J.; Peralta J.M.; de Freitas M.R.; Zalis M.; Puccioni-Sohler M.; Review of the etiologies of viral meningitis and encephalitis in a dengue endemic region. J Neurol Sci 2011,303(1-2),75-79","journal-title":"J Neurol Sci"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1017\/S0950268808001167","volume":"137","author":"Economopoulou A.","year":"2009","unstructured":"Economopoulou A.; Dominguez M.; Helynck B.; Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on R\u00e9union. Epidemiol Infect 2009,137(4),534-541","journal-title":"Epidemiol Infect"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1177\/0883073808314151","volume":"23","author":"Robin S.","year":"2008","unstructured":"Robin S.; Ramful D.; Le Seach\u2019 F.; Jaffar-Bandjee M.C.; Rigou G.; Alessandri J.L.; Neurologic manifestations of pediatric chikungunya infection. J Child Neurol 2008,23(9),1028-1035","journal-title":"J Child Neurol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1128\/CMR.17.4.903-925.2004","volume":"17","author":"Debiasi R.L.","year":"2004","unstructured":"Debiasi R.L.; Tyler K.L.; Molecular methods for diagnosis of viral encephalitis. Clin Microbiol Rev 2004,17(4),903-925","journal-title":"Clin Microbiol Rev"},{"key":"ref=56","doi-asserted-by":"publisher","author":"Griffin D.E.","unstructured":"Griffin D.E.; Role of Apoptosis in Infection. 2005; 289: pp. 57-77","DOI":"10.1007\/3-540-27320-4_3"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.coviro.2011.05.021","volume":"1","author":"Griffin D.E.","year":"2011","unstructured":"Griffin D.E.; Metcalf T.; Clearance of virus infection from the CNS. Curr Opin Virol 2011,1(3),216-221","journal-title":"Curr Opin Virol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.clinmicnews.2015.02.004","volume":"37","author":"Zueter A.M.","year":"2015","unstructured":"Zueter A.M.; Zaiter A.; Infectious meningitis. Clin Microbiol Newsl 2015,37,43-51","journal-title":"Clin Microbiol Newsl"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/01.idc.0000175819.56238.7e","volume":"13","author":"Liu S.C.","year":"2005","unstructured":"Liu S.C.; Lee P.I.; Lee C.Y.; Wang J.D.; Chiang B.L.; Chou M.C.; Different cytokine levels in enterovirus meningitis and encephalitis. Infect Dis Clin Pract 2005,13,241-246","journal-title":"Infect Dis Clin Pract"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.1038\/nm1144","volume":"10","author":"Mackenzie J.S.","year":"2004","unstructured":"Mackenzie J.S.; Gubler D.J.; Petersen L.R.; Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 2004,10(12)(Suppl.),S98-S109","journal-title":"Nat Med"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1056\/NEJM200106143442401","volume":"344","author":"Nash D.","year":"2001","unstructured":"Nash D.; Mostashari F.; Fine A.; 1999 West Nile Outbreak Response Working Group. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001,344(24),1807-1814","journal-title":"N Engl J Med"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1093\/infdis\/157.2.351","volume":"157","author":"Tsai T.F.","year":"1988","unstructured":"Tsai T.F.; Canfield M.A.; Reed C.M.; Epidemiological aspects of a St. Louis encephalitis outbreak in Harris County, Texas, 1986. J Infect Dis 1988,157(2),351-356","journal-title":"J Infect Dis"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1542\/peds.52.5.680","volume":"52","author":"Balfour H.H.","year":"1973","unstructured":"Balfour H.H.; Siem R.A.; Bauer H.; Quie P.G.; California arbovirus (La Crosse) infections. I. Clinical and laboratory findings in 66 children with meningoencephalitis. Pediatrics 1973,52(5),680-691","journal-title":"Pediatrics"},{"key":"ref=64","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008578","author":"Shu M","unstructured":"Shu M; Zhang YQ; Li Z; Liu GJ; Evertsen JM; Wan C; Chinese medicinal herbs for mumps Cochrane Database Syst Rev 2010; 7CD008578","journal-title":"Chinese medicinal herbs for mumps"},{"key":"ref=65","first-page":"57A","volume":"11","author":"Tyler K.L.","year":"2004","unstructured":"Tyler K.L.; Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret\u2019s. Herpes 2004,11(Suppl. 2),57A-64A","journal-title":"Herpes"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/0002-9343(87)90635-8","volume":"83","author":"Hollander H.","year":"1987","unstructured":"Hollander H.; Stringari S.; Human immunodeficiency virus-associated meningitis. Clinical course and correlations. Am J Med 1987,83(5),813-816","journal-title":"Am J Med"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1080\/135502801753170255","volume":"7","author":"Koskiniemi M.","year":"2001","unstructured":"Koskiniemi M.; Rantalaiho T.; Piiparinen H.; Infections of the central nervous system of suspected viral origin: a collaborative study from Finland. J Neurovirol Study Group2001,7(5),400-408","journal-title":"J Neurovirol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1055\/s-2000-9427","volume":"20","author":"Rotbart H.A.","year":"2000","unstructured":"Rotbart H.A.; Viral meningitis. Semin Neurol 2000,20(3),277-292","journal-title":"Semin Neurol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"6051","DOI":"10.3390\/v7112920","volume":"7","author":"Huang H.I.","year":"2015","unstructured":"Huang H.I.; Shih S.R.; Neurotropic enterovirus infections in the central nervous system. Viruses 2015,7(11),6051-6066","journal-title":"Viruses"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/clinids\/9.2.334","volume":"9","author":"McKinney R.E.","year":"1987","unstructured":"McKinney R.E.; Katz S.L.; Wilfert C.M.; Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev Infect Dis 1987,9(2),334-356","journal-title":"Rev Infect Dis"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/bmb\/ldh057","volume":"75-76","author":"Chadwick D.R.","year":"2006","unstructured":"Chadwick D.R.; Viral meningitis. Br Med Bull 2006,75-76,1-14","journal-title":"Br Med Bull"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00401-015-1511-3","volume":"131","author":"Ludlow M.","year":"2016","unstructured":"Ludlow M.; Kortekaas J.; Herden C.; Neurotropic virus infections as the cause of immediate and delayed neuropathology. Acta Neuropathol 2016,131(2),159-184","journal-title":"Acta Neuropathol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.nic.2015.01.005","volume":"25","author":"Yokota H.","year":"2015","unstructured":"Yokota H.; Yamada K.; Viral infection of the spinal cord and roots. Neuroimaging Clin N Am 2015,25(2),247-258","journal-title":"Neuroimaging Clin N Am"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/rmv.606","volume":"19","author":"Arpino C.","year":"2009","unstructured":"Arpino C.; Curatolo P.; Rezza G.; Chikungunya and the nervous system: what we do and do not know. Rev Med Virol 2009,19(3),121-129","journal-title":"Rev Med Virol"},{"key":"ref=75","first-page":"190","volume":"29","author":"Erasmus M.","year":"2011","unstructured":"Erasmus M.; Viral infections of the central nervous system. CME 2011,29,190-193","journal-title":"CME"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/ana.24730","volume":"80","author":"Messacar K.","year":"2016","unstructured":"Messacar K.; Schreiner T.L.; Van Haren K.; Acute flaccid myelitis: A clinical review of US cases 2012-2015. Ann Neurol 2016,80(3),326-338","journal-title":"Ann Neurol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.virol.2010.12.014","volume":"411","author":"Rhoades R.E.","year":"2011","unstructured":"Rhoades R.E.; Tabor-Godwin J.M.; Tsueng G.; Feuer R.; Enterovirus infections of the central nervous system. Virology 2011,411(2),288-305","journal-title":"Virology"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1017\/S0950268807009739","volume":"136","author":"Singh S.S.","year":"2008","unstructured":"Singh S.S.; Manimunda S.P.; Sugunan A.P.; Sahina, Vijayachari P. Four cases of acute flaccid paralysis associated with chikungunya virus infection. Epidemiol Infect 2008,136(9),1277-1280","journal-title":"Epidemiol Infect"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2174\/157488910791213149","volume":"5","year":"2010","unstructured":"A Anderson R. Role of dietary polyphenols in attenuating brain edema and cell swelling in cerebral ischemia. Recent Patents CNS Drug Discov 2010,5,99-108","journal-title":"Recent Patents CNS Drug Discov"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s00705-016-2749-3","volume":"161","author":"Galochkina A.V.","year":"2016","unstructured":"Galochkina A.V.; Anikin V.B.; Babkin V.A.; Ostrouhova L.A.; Zarubaev V.V.; Virus-inhibiting activity of dihydroquercetin, a flavonoid from Larix sibirica, against coxsackievirus B4 in a model of viral pancreatitis. Arch Virol 2016,161(4),929-938","journal-title":"Arch Virol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jnutbio.2009.04.004","volume":"20","author":"Andres A.","year":"2009","unstructured":"Andres A.; Donovan S.M.; Kuhlenschmidt M.S.; Soy isoflavones and virus infections. J Nutr Biochem 2009,20(8),563-569","journal-title":"J Nutr Biochem"},{"key":"ref=82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030259","volume":"7","author":"Zhang T.","year":"2012","unstructured":"Zhang T.; Wu Z.; Du J.; Anti-Japanese-encephalitis-viral effects of kaempferol and daidzin and their RNA-binding characteristics. PLoS One 2012,7(1)","journal-title":"PLoS One"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1745-7254.2006.00238.x","volume":"27","author":"Hendrich A.B.","year":"2006","unstructured":"Hendrich A.B.; Flavonoid-membrane interactions: possible consequences for biological effects of some polyphenolic compounds. Acta Pharmacol Sin 2006,27(1),27-40","journal-title":"Acta Pharmacol Sin"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3390\/i8090950","volume":"8","author":"Han X.","year":"2007","unstructured":"Han X.; Shen T.; Lou H.; Dietary polyphenols and their biological significance. Int J Mol Sci 2007,8,950-988","journal-title":"Int J Mol Sci"},{"key":"ref=85","author":"H\u00e4m\u00e4l\u00e4inen M.","year":"2007","unstructured":"H\u00e4m\u00e4l\u00e4inen M.; Nieminen R.; Vuorela P.; Heinonen M.; Moilanen E.; Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-\u03baB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-\u03baB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm. Int J Mol Sci 2007","journal-title":"Int J Mol Sci"},{"key":"ref=86","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/162750","volume":"2013","author":"Kumar S","year":"2013","unstructured":"Kumar S; Pandey AK; Chemistry and biological activities of flavonoids: an overview. Sci World J 2013,2013","journal-title":"Sci World J"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/ptr.6063","volume":"32","author":"Bedrood Z.","year":"2018","unstructured":"Bedrood Z.; Rameshrad M.; Hosseinzadeh H.; Toxicological effects of Camellia sinensis (green tea): A review. Phytother Res 2018,32(7),1163-1180","journal-title":"Phytother Res"},{"key":"ref=88","doi-asserted-by":"publisher","DOI":"10.1080\/16546628.2017.1361779","volume":"61","author":"Khoo H.E.","year":"2017","unstructured":"Khoo H.E.; Azlan A.; Tang S.T.; Lim S.M.; Anthocyanidins and anthocyanins: colored pigments as food, pharmaceutical ingredients, and the potential health benefits. Food Nutr Res 2017,61(1)","journal-title":"Food Nutr Res"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1208\/s12249-015-0329-6","volume":"16","author":"Franklin S.J.","year":"2015","unstructured":"Franklin S.J.; Myrdal P.B.; Solid-state and solution characterization of myricetin. AAPS PharmSciTech 2015,16(6),1400-1408","journal-title":"AAPS PharmSciTech"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/j.1348-0421.2003.tb03431.x","volume":"47","author":"Minami M.","year":"2003","unstructured":"Minami M.; Kita M.; Nakaya T.; Yamamoto T.; Kuriyama H.; Imanishi J.; The inhibitory effect of essential oils on herpes simplex virus type-1 replication in vitro. Microbiol Immunol 2003,47(9),681-684","journal-title":"Microbiol Immunol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jacme.2015.07.001","volume":"5","author":"Gavanji S.","year":"2015","unstructured":"Gavanji S.; Sayedipour S.S.; Larki B.; Bakhtari A.; Antiviral activity of some plant oils against herpes simplex virus type 1 in Vero cell culture. Acute Med 2015,5,62-68","journal-title":"Acute Med"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.3390\/nu7042345","volume":"7","author":"Nishimuro H.","year":"2015","unstructured":"Nishimuro H.; Ohnishi H.; Sato M.; Estimated daily intake and seasonal food sources of quercetin in Japan. Nutrients 2015,7(4),2345-2358","journal-title":"Nutrients"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.biopha.2016.10.011","volume":"84","author":"Suganthy N.","year":"2016","unstructured":"Suganthy N.; Devi K.P.; Nabavi S.F.; Braidy N.; Nabavi S.M.; Bioactive effects of quercetin in the central nervous system: Focusing on the mechanisms of actions. Biomed Pharmacother 2016,84,892-908","journal-title":"Biomed Pharmacother"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/0140-6736(93)92876-U","volume":"342","author":"Hertog M.G.","year":"1993","unstructured":"Hertog M.G.; Feskens E.J.; Hollman P.C.; Katan M.B.; Kromhout D.; Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993,342(8878),1007-1011","journal-title":"Lancet"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jviromet.2011.03.019","volume":"174","author":"Coelho-Dos-Reis J.G.A.","year":"2011","unstructured":"Coelho-Dos-Reis J.G.A.; Gomes O.A.; Bortolini D.E.; Evaluation of the effects of Quercetin and Kaempherol on the surface of MT-2 cells visualized by atomic force microscopy. J Virol Methods 2011,174(1-2),47-52","journal-title":"J Virol Methods"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"16785","DOI":"10.3390\/ijms131216785","volume":"13","author":"Johari J.","year":"2012","unstructured":"Johari J.; Kianmehr A.; Mustafa M.R.; Abubakar S.; Zandi K.; Antiviral activity of baicalein and quercetin against the Japanese encephalitis virus. Int J Mol Sci 2012,13(12),16785-16795","journal-title":"Int J Mol Sci"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1186\/1743-422X-8-560","volume":"8","author":"Zandi K.","year":"2011","unstructured":"Zandi K.; Teoh B.T.; Sam S.S.; Wong P.F.; Mustafa M.R.; Abubakar S.; Antiviral activity of four types of bioflavonoid against dengue virus type-2. Virol J 2011,8,560","journal-title":"Virol J"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1111\/j.1365-2893.2011.01507.x","volume":"19","author":"Bachmetov L.","year":"2012","unstructured":"Bachmetov L.; Gal-Tanamy M.; Shapira A.; Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity. J Viral Hepat 2012,19(2),e81-e88","journal-title":"J Viral Hepat"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0166-3542(81)90015-2","volume":"1","author":"Veckenstedt A.","year":"1981","unstructured":"Veckenstedt A.; Pusztai R.; Mechanism of antiviral action of quercetin against cardiovirus infection in mice. Antiviral Res 1981,1(4),249-261","journal-title":"Antiviral Res"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s12272-017-0898-x","volume":"40","author":"Lee S.","year":"2017","unstructured":"Lee S.; Lee H.H.; Shin Y.S.; Kang H.; Cho H.; The anti-HSV-1 effect of quercetin is dependent on the suppression of TLR-3 in Raw 264.7 cells. Arch Pharm Res 2017,40(5),623-630","journal-title":"Arch Pharm Res"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.fitote.2011.04.007","volume":"82","author":"Fan D.","year":"2011","unstructured":"Fan D.; Zhou X.; Zhao C.; Chen H.; Zhao Y.; Gong X.; Antiviral and quantitative study of quercetin-3-O-b-D-glucuronide in Polygonum perfoliatum L. Fitoterapia 2011,82,805-810","journal-title":"Fitoterapia"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1186\/1743-422X-8-460","volume":"8","author":"Song J.H.","year":"2011","unstructured":"Song J.H.; Shim J.K.; Choi H.J.; Quercetin 7-rhamnoside reduces porcine epidemic diarrhea virus replication via independent pathway of viral induced reactive oxygen species. Virol J 2011,8,460","journal-title":"Virol J"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.1016\/j.bmcl.2012.04.028","volume":"22","author":"Dao T.T.","year":"2012","unstructured":"Dao T.T.; Dang T.T.; Nguyen P.H.; Kim E.; Thuong P.T.; Oh W.K.; Xanthones from Polygala karensium inhibit neuraminidases from influenza A viruses. Bioorg Med Chem Lett 2012,22(11),3688-3692","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.bmcl.2010.11.016","volume":"21","author":"Dao T.T.","year":"2011","unstructured":"Dao T.T.; Nguyen P.H.; Lee H.S.; Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflata. Bioorg Med Chem Lett 2011,21(1),294-298","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1472-6882-11-16","volume":"11","author":"Krawitz C.","year":"2011","unstructured":"Krawitz C.; Mraheil M.A.; Stein M.; Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B viruses. BMC Complement Altern Med 2011,11,16","journal-title":"BMC Complement Altern Med"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1186\/1743-422X-8-538","volume":"8","author":"He W.","year":"2011","unstructured":"He W.; Han H.; Wang W.; Gao B.; Anti-influenza virus effect of aqueous extracts from dandelion. Virol J 2011,8,538","journal-title":"Virol J"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1248\/bpb.35.786","volume":"35","author":"Jeong H.J.","year":"2012","unstructured":"Jeong H.J.; Kim Y.M.; Kim J.H.; Homoisoflavonoids from Caesalpinia sappan displaying viral neuraminidases inhibition. Biol Pharm Bull 2012,35(5),786-790","journal-title":"Biol Pharm Bull"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.antiviral.2012.03.006","volume":"94","author":"Theisen L.L.","year":"2012","unstructured":"Theisen L.L.; Muller C.P.; EPs\u00ae 7630 (Umckaloabo\u00ae), an extract from Pelargonium sidoides roots, exerts anti-influenza virus activity in vitro and in vivo. Antiviral Res 2012,94(2),147-156","journal-title":"Antiviral Res"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"4450","DOI":"10.1021\/ol401992s","volume":"15","author":"Ma S.G.","year":"2013","unstructured":"Ma S.G.; Gao R.M.; Li Y.H.; Antiviral spirooliganones A and B with unprecedented skeletons from the roots of Illicium oligandrum. Org Lett 2013,15(17),4450-4453","journal-title":"Org Lett"},{"key":"ref=110","first-page":"12","volume":"12","author":"Admasu P.","year":"2014","unstructured":"Admasu P.; Deressa A.; Mengistu A.; Gebrewold G.; Feyera T.; In vivo antirabies activity evaluation of hydroethanolic extract of roots and leaves of Phytolacca dodecandra. Glob Vet 2014,12,12-18","journal-title":"Glob Vet"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1678-9199-20-45","volume":"20","author":"Vigerelli H.","year":"2014","unstructured":"Vigerelli H.; Sciani J.M.; Jared C.; Bufotenine is able to block rabies virus infection in BHK-21 cells. J Venom Anim Toxins Incl Trop Dis 2014,20(1),45","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.tox.2004.05.008","volume":"202","author":"Koh S.H.","year":"2004","unstructured":"Koh S.H.; Kwon H.; Kim K.S.; Epigallocatechin gallate prevents oxidative-stress-induced death of mutant Cu\/Zn-superoxide dismutase (G93A) motoneuron cells by alteration of cell survival and death signals. Toxicology 2004,202(3),213-225","journal-title":"Toxicology"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.1021\/jf901128u","volume":"57","author":"Ho H.Y.","year":"2009","unstructured":"Ho H.Y.; Cheng M.L.; Weng S.F.; Leu Y.L.; Chiu D.T.Y.; Antiviral effect of epigallocatechin gallate on enterovirus 71. J Agric Food Chem 2009,57(14),6140-6147","journal-title":"J Agric Food Chem"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1472-765X.2010.02805.x","volume":"50","author":"Choi H.J.","year":"2010","unstructured":"Choi H.J.; Song J.H.; Park K.S.; Baek S.H.; In vitro anti-enterovirus 71 activity of gallic acid from Woodfordia fruticosa flowers. Lett Appl Microbiol 2010,50(4),438-440","journal-title":"Lett Appl Microbiol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"12264","DOI":"10.1038\/s41598-017-12388-2","volume":"7","author":"Chen S.G.","year":"2017","unstructured":"Chen S.G.; Leu Y.L.; Cheng M.L.; Anti-enterovirus 71 activities of Melissa officinalis extract and its biologically active constituent rosmarinic acid. Sci Rep 2017,7(1),12264","journal-title":"Sci Rep"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/j.1440-1681.2005.04270.x","volume":"32","author":"Chiang L.C.","year":"2005","unstructured":"Chiang L.C.; Ng L.T.; Cheng P.W.; Chiang W.; Lin C.C.; Antiviral activities of extracts and selected pure constituents of Ocimum basilicum. Clin Exp Pharmacol Physiol 2005,32(10),811-816","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1142\/S0192415X07004709","volume":"35","author":"Wu B.W.","year":"2007","unstructured":"Wu B.W.; Pan T.L.; Leu Y.L.; Antiviral effects of Salvia miltiorrhiza (Danshen) against enterovirus 71. Am J Chin Med 2007,35(1),153-168","journal-title":"Am J Chin Med"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ejphar.2015.02.046","volume":"755","author":"Chung Y.C.","year":"2015","unstructured":"Chung Y.C.; Hsieh F.C.; Lin Y.J.; Magnesium lithospermate B and rosmarinic acid, two compounds present in Salvia miltiorrhiza, have potent antiviral activity against enterovirus 71 infections. Eur J Pharmacol 2015,755,127-133","journal-title":"Eur J Pharmacol"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/s41598-017-01110-x","volume":"7","author":"Chen S.G.","year":"2017","unstructured":"Chen S.G.; Cheng M.L.; Chen K.H.; Antiviral activities of Schizonepeta tenuifolia Briq. against enterovirus 71 in vitro and in vivo. Sci Rep 2017,7(1),935","journal-title":"Sci Rep"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jep.2013.02.017","volume":"147","author":"Wang J.","year":"2013","unstructured":"Wang J.; Chen X.; Wang W.; Glycyrrhizic acid as the antiviral component of Glycyrrhiza uralensis Fisch. against coxsackievirus A16 and enterovirus 71 of hand foot and mouth disease. J Ethnopharmacol 2013,147(1),114-121","journal-title":"J Ethnopharmacol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.bbrc.2014.05.019","volume":"449","author":"Zhang W.","year":"2014","unstructured":"Zhang W.; Tao J.; Yang X.; Antiviral effects of two Ganoderma lucidum triterpenoids against enterovirus 71 infection. Biochem Biophys Res Commun 2014,449(3),307-312","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.fct.2006.06.007","volume":"45","author":"Cheng P.W.","year":"2007","unstructured":"Cheng P.W.; Chiang L.C.; Yen M.H.; Lin C.C.; Bupleurum kaoi inhibits Coxsackie B virus type 1 infection of CCFS-1 cells by induction of type I interferons expression. Food Chem Toxicol 2007,45(1),24-31","journal-title":"Food Chem Toxicol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.phymed.2008.10.012","volume":"16","author":"Choi H.J.","year":"2009","unstructured":"Choi H.J.; Lim C.H.; Song J.H.; Baek S.H.; Kwon D.H.; Antiviral activity of raoulic acid from Raoulia australis against Picornaviruses. Phytomedicine 2009,16(1),35-39","journal-title":"Phytomedicine"},{"key":"ref=124","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078425","volume":"8","author":"Fang J.","year":"2013","unstructured":"Fang J.; Sun L.; Peng G.; Identification of three antiviral inhibitors against Japanese encephalitis virus from library of pharmacologically active compounds 1280. PLoS One 2013,8(11)","journal-title":"PLoS One"},{"key":"ref=125","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/461461","author":"Rupareliya R.H.","year":"2013","unstructured":"Rupareliya R.H.; Joshi H.S.; Stability Indicating Simultaneous Validation of Telmisartan and Cilnidipine with Forced Degradation Behavior Study by RP-HPLC in Tablet Dosage Form 2013","journal-title":"Stability Indicating Simultaneous Validation of Telmisartan and Cilnidipine with Forced Degradation Behavior Study by RP-HPLC in Tablet Dosage Form"},{"key":"ref=126","first-page":"14","author":"Chang Y.W.","year":"2006","unstructured":"Chang Y.W.; Yeh T.K.; Lin K.T.; Chen W.C.; Yao H.T.; Pharmacokinetics of anti-SARS-CoV agent niclosamide and its analogs in rats. Yao Wu Shi Pin Fen Xi 2006,14","journal-title":"Yao Wu Shi Pin Fen Xi"},{"key":"ref=127","unstructured":"FGIN-1-27. Item No. 18461 (caymanchem) xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" https:\/\/www.caymanchem.com\/product\/18461 [March 8, 2019]"},{"key":"ref=128","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/925830","author":"Chang S.J.","year":"2012","unstructured":"Chang S.J.; Chang Y.C.; Lu K.Z.; Tsou Y.Y.; Lin C.W.; Antiviral activity of Isatis indigotica extract and its derived indirubin against Japanese encephalitis virus. Evid Based Complement Alternat Med 2012","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.antiviral.2008.03.001","volume":"79","author":"Li J.","year":"2008","unstructured":"Li J.; Huang H.; Feng M.; Zhou W.; Shi X.; Zhou P.; In vitro and in vivo anti-hepatitis B virus activities of a plant extract from Geranium carolinianum L. Antiviral Res 2008,79(2),114-120","journal-title":"Antiviral Res"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"6816","DOI":"10.1016\/j.bmc.2009.08.036","volume":"17","author":"Jeong H.J.","year":"2009","unstructured":"Jeong H.J.; Ryu Y.B.; Park S.J.; Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities. Bioorg Med Chem 2009,17(19),6816-6823","journal-title":"Bioorg Med Chem"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.3390\/molecules19022536","volume":"19","author":"Shin H.S.","year":"2014","unstructured":"Shin H.S.; Bae M.J.; Choi D.W.; Shon D.H.; Skullcap (Scutellaria baicalensis) extract and its active compound, wogonin, inhibit ovalbumin-induced Th2-mediated response. Molecules 2014,19(2),2536-2545","journal-title":"Molecules"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0166-3542(97)00058-2","volume":"37","author":"Takegami T.","year":"1998","unstructured":"Takegami T.; Simamura E.; Hirai K.; Koyama J.; Inhibitory effect of furanonaphthoquinone derivatives on the replication of Japanese encephalitis virus. Antiviral Res 1998,37(1),37-45","journal-title":"Antiviral Res"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1039\/p19910002323","volume":"10","author":"Fujimoto Y.","year":"1991","unstructured":"Fujimoto Y.; Eguchi T.; Murasaki C.; Studies on the structure and stereochemistry of cytotoxic furanonaphthoquinones from Tabebuia impetiginosa: 5-and 8-hydroxy-2-(1-hydroxyethyl) naphtho [2, 3-b] furan-4, 9-diones. J Chem Soc, Perkin Trans 1 1991,10,2323-2327","journal-title":"J Chem Soc, Perkin Trans 1"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1248\/bpb.19.1166","volume":"19","author":"Kajimura K.","year":"1996","unstructured":"Kajimura K.; Takagi Y.; Ueba N.; Protective effect of astragali radix by oral administration against Japanese encephalitis virus infection in mice. Biol Pharm Bull 1996,19(9),1166-1169","journal-title":"Biol Pharm Bull"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijid.2014.02.011","volume":"24","author":"Zhang Y.","year":"2014","unstructured":"Zhang Y.; Wang Z.; Chen H.; Chen Z.; Tian Y.; Antioxidants: potential antiviral agents for Japanese encephalitis virus infection. Int J Infect Dis 2014,24,30-36","journal-title":"Int J Infect Dis"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.neuint.2009.01.022","volume":"54","author":"Mishra M.K.","year":"2009","unstructured":"Mishra M.K.; Ghosh D.; Duseja R.; Basu A.; Antioxidant potential of Minocycline in Japanese Encephalitis Virus infection in murine neuroblastoma cells: correlation with membrane fluidity and cell death. Neurochem Int 2009,54(7),464-470","journal-title":"Neurochem Int"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/mnfr.200700316","volume":"52","author":"Calabrese V.","year":"2008","unstructured":"Calabrese V.; Bates T.E.; Mancuso C.; Curcumin and the cellular stress response in free radical-related diseases. Mol Nutr Food Res 2008,52(9),1062-1073","journal-title":"Mol Nutr Food Res"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5505\/tjtes.2011.31391","volume":"17","author":"Sahin Kavakl\u0131 H.","year":"2011","unstructured":"Sahin Kavakl\u0131 H.; Koca C.; Al\u0131c\u0131 O.; Antioxidant effects of curcumin in spinal cord injury in rats. Ulus Travma Acil Cerrahi Derg 2011,17(1),14-18","journal-title":"Ulus Travma Acil Cerrahi Derg"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"81","DOI":"10.15412\/J.BCN.03070201","volume":"7","author":"Ataie A.","year":"2016","unstructured":"Ataie A.; Shadifar M.; Ataee R.; Polyphenolic antioxidants and neuronal regeneration. Basic Clin Neurosci 2016,7(2),81-90","journal-title":"Basic Clin Neurosci"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/10408690490424702","volume":"44","author":"Joe B.","year":"2004","unstructured":"Joe B.; Vijaykumar M.; Lokesh B.R.; Biological properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr 2004,44(2),97-111","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s11481-009-9158-2","volume":"4","author":"Dutta K.","year":"2009","unstructured":"Dutta K.; Ghosh D.; Basu A.; Curcumin protects neuronal cells from Japanese encephalitis virus-mediated cell death and also inhibits infective viral particle formation by dysregulation of ubiquitin-proteasome system. J Neuroimmune Pharmacol 2009,4(3),328-337","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.foodchem.2012.01.106","volume":"133","author":"Kaz\u0142owski B.","year":"2012","unstructured":"Kaz\u0142owski B.; Chiu Y.H.; Kaz\u0142owska K.; Pan C.L.; Wu C.J.; Prevention of Japanese encephalitis virus infections by low-degree-polymerisation sulfated saccharides from Gracilaria sp. and Monostroma nitidum. Food Chem 2012,133,866-874","journal-title":"Food Chem"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.antiviral.2011.06.015","volume":"92","author":"Bertol J.W.","year":"2011","unstructured":"Bertol J.W.; Rigotto C.; de P\u00e1dua R.M.; Antiherpes activity of glucoevatromonoside, a cardenolide isolated from a Brazilian cultivar of Digitalis lanata. Antiviral Res 2011,92(1),73-80","journal-title":"Antiviral Res"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1016\/j.tripleo.2011.04.007","volume":"112","author":"Danaher R.J.","year":"2011","unstructured":"Danaher R.J.; Wang C.; Dai J.; Mumper R.J.; Miller C.S.; Antiviral effects of blackberry extract against herpes simplex virus type 1. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011,112(3),e31-e35","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.fitote.2010.11.022","volume":"82","author":"Gescher K.","year":"2011","unstructured":"Gescher K.; K\u00fchn J.; Hafezi W.; Inhibition of viral adsorption and penetration by an aqueous extract from Rhododendron ferrugineum L. as antiviral principle against herpes simplex virus type-1. Fitoterapia 2011,82(3),408-413","journal-title":"Fitoterapia"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jep.2010.12.038","volume":"134","author":"Gescher K.","year":"2011","unstructured":"Gescher K.; K\u00fchn J.; Lorentzen E.; Proanthocyanidin-enriched extract from Myrothamnus flabellifolia Welw. exerts antiviral activity against herpes simplex virus type 1 by inhibition of viral adsorption and penetration. J Ethnopharmacol 2011,134(2),468-474","journal-title":"J Ethnopharmacol"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1021\/ol300017m","volume":"14","author":"Chen S.D.","year":"2012","unstructured":"Chen S.D.; Gao H.; Zhu Q.C.; Houttuynoids A-E, anti-herpes simplex virus active flavonoids with novel skeletons from Houttuynia cordata. Org Lett 2012,14(7),1772-1775","journal-title":"Org Lett"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s12250-008-2962-7","volume":"23","author":"Xiang Y.F.","year":"2008","unstructured":"Xiang Y.F.; Pei Y.; Wang Y.F.; Current status of natural products from plants as anti-herpes simplex virus 1 agents. Virol Sin 2008,23,305","journal-title":"Virol Sin"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.phymed.2007.09.003","volume":"15","author":"Koch C.","year":"2008","unstructured":"Koch C.; Reichling J.; Schneele J.; Schnitzler P.; Inhibitory effect of essential oils against herpes simplex virus type 2. Phytomedicine 2008,15(1-2),71-78","journal-title":"Phytomedicine"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1248\/cpb.39.112","volume":"39","author":"Hirabayashi K.","year":"1991","unstructured":"Hirabayashi K.; Iwata S.; Matsumoto H.; Antiviral activities of glycyrrhizin and its modified compounds against human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 1 (HSV-1) in vitro. Chem Pharm Bull (Tokyo) 1991,39(1),112-115","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12250-010-3092-6","volume":"25","author":"Ren Z.","year":"2010","unstructured":"Ren Z.; Zhang C.H.; Wang L.J.; In vitro anti-viral activity of the total alkaloids from Tripterygium hypoglaucum against herpes simplex virus type 1. Virol Sin 2010,25(2),107-114","journal-title":"Virol Sin"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.phymed.2008.04.018","volume":"15","author":"Schnitzler P.","year":"2008","unstructured":"Schnitzler P.; Schuhmacher A.; Astani A.; Reichling J.; Melissa officinalis oil affects infectivity of enveloped herpesviruses. Phytomedicine 2008,15(9),734-740","journal-title":"Phytomedicine"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000335590","volume":"58","author":"Astani A.","year":"2012","unstructured":"Astani A.; Reichling J.; Schnitzler P.; Melissa officinalis extract inhibits attachment of herpes simplex virus in vitro. Chemotherapy 2012,58(1),70-77","journal-title":"Chemotherapy"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1099\/jmm.0.46110-0","volume":"55","author":"Cheng H.Y.","year":"2006","unstructured":"Cheng H.Y.; Yang C.M.; Lin T.C.; Shieh D.E.; Lin C.C.; ent-Epiafzelechin-(4alpha-->8)-epiafzelechin extracted from Cassia javanica inhibits herpes simplex virus type 2 replication. J Med Microbiol 2006,55(Pt 2),201-206","journal-title":"J Med Microbiol"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1002\/ptr.2850","volume":"23","author":"Petrera E.","year":"2009","unstructured":"Petrera E.; Coto C.E.; Therapeutic effect of meliacine, an antiviral derived from Melia azedarach L., in mice genital herpetic infection. Phytother Res 2009,23(12),1771-1777","journal-title":"Phytother Res"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4103\/2225-4110.124335","volume":"4","author":"Lin L.T.","year":"2014","unstructured":"Lin L.T.; Hsu W.C.; Lin C.C.; Antiviral natural products and herbal medicines. J Tradit Complement Med 2014,4(1),24-35","journal-title":"J Tradit Complement Med"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jep.2006.09.039","volume":"110","author":"Yang C.M.","year":"2007","unstructured":"Yang C.M.; Cheng H.Y.; Lin T.C.; Chiang L.C.; Lin C.C.; The in vitro activity of geraniin and 1,3,4,6-tetra-O-galloyl-\u03b2-D-glucose isolated from Phyllanthus urinaria against herpes simplex virus type 1 and type 2 infection. J Ethnopharmacol 2007,110(3),555-558","journal-title":"J Ethnopharmacol"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/ptr.2232","volume":"21","author":"Yang C.M.","year":"2007","unstructured":"Yang C.M.; Cheng H.Y.; Lin T.C.; Chiang L.C.; Lin C.C.; Hippomanin A from acetone extract of Phyllanthus urinaria inhibited HSV-2 but not HSV-1 infection in vitro. Phytother Res 2007,21(12),1182-1186","journal-title":"Phytother Res"},{"key":"ref=159","doi-asserted-by":"publisher","DOI":"10.1093\/ecam\/nep157","volume":"\u2022","author":"Cheng H.Y.","year":"2011","unstructured":"Cheng H.Y.; Yang C.M.; Lin T.C.; Lin L.T.; Chiang L.C.; Lin C.C.; Excoecarianin, isolated from Phyllanthus urinaria Linnea, inhibits herpes simplex virus type 2 infection through inactivation of viral particles. Evid Based Complement Alternat Med 2011,\u2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0141-8130(02)00070-3","volume":"31","author":"Mazumder S.","year":"2002","unstructured":"Mazumder S.; Ghosal P.K.; Pujol C.A.; Carlucci M.J.; Damonte E.B.; Ray B.; Isolation, chemical investigation and antiviral activity of polysaccharides from Gracilaria corticata (Gracilariaceae, Rhodophyta). Int J Biol Macromol 2002,31(1-3),87-95","journal-title":"Int J Biol Macromol"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1016\/j.carres.2005.08.004","volume":"340","author":"Matsuhiro B.","year":"2005","unstructured":"Matsuhiro B.; Conte A.F.; Damonte E.B.; Structural analysis and antiviral activity of a sulfated galactan from the red seaweed Schizymenia binderi (Gigartinales, Rhodophyta). Carbohydr Res 2005,340(15),2392-2402","journal-title":"Carbohydr Res"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3851\/IMP1884","volume":"16","author":"Low J.S.Y.","year":"2011","unstructured":"Low J.S.Y.; Wu K.X.; Chen K.C.; Ng M.M.; Chu J.J.H.; Narasin, a novel antiviral compound that blocks dengue virus protein expression. Antivir Ther (Lond) 2011,16(8),1203-1218","journal-title":"Antivir Ther (Lond)"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/1472-6882-12-214","volume":"12","author":"Zandi K.","year":"2012","unstructured":"Zandi K.; Teoh B.T.; Sam S.S.; Wong P.F.; Mustafa M.R.; Abubakar S.; Novel antiviral activity of baicalein against dengue virus. BMC Complement Altern Med 2012,12,214","journal-title":"BMC Complement Altern Med"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/1471-2180-13-187","volume":"13","author":"Lin L.T.","year":"2013","unstructured":"Lin L.T.; Chen T.Y.; Lin S.C.; Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry. BMC Microbiol 2013,13,187","journal-title":"BMC Microbiol"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1016\/j.carres.2005.10.001","volume":"340","author":"Rodr\u00edguez M.C.","year":"2005","unstructured":"Rodr\u00edguez M.C.; Merino E.R.; Pujol C.A.; Damonte E.B.; Cerezo A.S.; Matulewicz M.C.; Galactans from cystocarpic plants of the red seaweed Callophyllis variegata (Kallymeniaceae, Gigartinales). Carbohydr Res 2005,340(18),2742-2751","journal-title":"Carbohydr Res"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.carbpol.2005.09.020","volume":"63","year":"2006","unstructured":"Noseda MD, Guimar\u00e3es SMPB, Damonte EB, Duarte MER. Chemical structure and antiviral activity of carrageenans from Meristiella gelidium against herpes simplex and dengue virus. CARBOHYD POLYM de SF-Tischer PC Talarico LB2006,63,459-465","journal-title":"CARBOHYD POLYM"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1248\/bpb.27.1471","volume":"27","author":"Huerta-Reyes M.","year":"2004","unstructured":"Huerta-Reyes M.; Basualdo Mdel C.; Abe F.; Jimenez-Estrada M.; Soler C.; Reyes-Chilpa R.; HIV-1 inhibitory compounds from Calophyllum brasiliense leaves. Biol Pharm Bull 2004,27(9),1471-1475","journal-title":"Biol Pharm Bull"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.fitote.2011.06.006","volume":"82","author":"C\u00e9sar G.Z.J.","year":"2011","unstructured":"C\u00e9sar G.Z.J.; Alfonso M.G.G.; Marius M.M.; Inhibition of HIV-1 reverse transcriptase, toxicological and chemical profile of Calophyllum brasiliense extracts from Chiapas, Mexico. Fitoterapia 2011,82(7),1027-1034","journal-title":"Fitoterapia"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.jep.2012.03.024","volume":"141","author":"Lubbe A.","year":"2012","unstructured":"Lubbe A.; Seibert I.; Klimkait T.; van der Kooy F.; Ethnopharmacology in overdrive: the remarkable anti-HIV activity of Artemisia annua. J Ethnopharmacol 2012,141(3),854-859","journal-title":"J Ethnopharmacol"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1055\/s-1999-13971","volume":"65","author":"Lin Y.M.","year":"1999","unstructured":"Lin Y.M.; Flavin M.T.; Schure R.; Antiviral activities of biflavonoids. Planta Med 1999,65(2),120-125","journal-title":"Planta Med"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/ptr.2362","volume":"22","author":"Asl M.N.","year":"2008","unstructured":"Asl M.N.; Hosseinzadeh H.; Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res 2008,22(6),709-724","journal-title":"Phytother Res"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1021\/jm051229y","volume":"49","author":"Goodell J.R.","year":"2006","unstructured":"Goodell J.R.; Puig-Basagoiti F.; Forshey B.M.; Shi P.Y.; Ferguson D.M.; Identification of compounds with anti-West Nile Virus activity. J Med Chem 2006,49(6),2127-2137","journal-title":"J Med Chem"}],"container-title":["Current Drug Discovery Technologies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/173471","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/173471\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/173471","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T00:03:17Z","timestamp":1663977797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/173471\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,8]]},"references-count":172,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,9,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570163816666190715114741","relation":{},"ISSN":["1570-1638"],"issn-type":[{"value":"1570-1638","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-12-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}